• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对氨基糖苷类抗生素的耐药机制。

Mechanisms of resistance to aminoglycosides.

作者信息

Davies J, Courvalin P

出版信息

Am J Med. 1977 Jun;62(6):868-72. doi: 10.1016/0002-9343(77)90654-4.

DOI:10.1016/0002-9343(77)90654-4
PMID:868900
Abstract

Bacterial resistance to aminoglycoside antibiotics occurs by a variety of mechanisms. In clinical situations the most common mechanism is plasmid-determined modification of the drug that leads to a block of transport of the antibiotic into the cell. Amikacin, a semisynthetic aminoglycoside, is effective against a number of resistant strains because it has fewer sites of modification.

摘要

细菌对氨基糖苷类抗生素产生耐药性的机制多种多样。在临床情况下,最常见的机制是由质粒决定的药物修饰,这会导致抗生素进入细胞的转运受阻。阿米卡星是一种半合成氨基糖苷类抗生素,对许多耐药菌株有效,因为它的修饰位点较少。

相似文献

1
Mechanisms of resistance to aminoglycosides.对氨基糖苷类抗生素的耐药机制。
Am J Med. 1977 Jun;62(6):868-72. doi: 10.1016/0002-9343(77)90654-4.
2
In-vivo acquisition of two different types of aminoglycoside resistance by a single strain of Klebsiella pneumoniae causing severe infection.一株引起严重感染的肺炎克雷伯菌在体内获得两种不同类型的氨基糖苷类耐药性。
Ann Intern Med. 1982 Feb;96(2):176-80. doi: 10.7326/0003-4819-96-2-176.
3
Aminoglycoside resistance in Pseudomonas aeruginosa isolated from cystic fibrosis patients.从囊性纤维化患者中分离出的铜绿假单胞菌对氨基糖苷类抗生素的耐药性。
Am J Clin Pathol. 1984 Jun;81(6):742-7. doi: 10.1093/ajcp/81.6.742.
4
[The antimicrobial activity of amikacin in comparison with three other aminoglycoside-antibiotics (author's transl)].丁胺卡那霉素与其他三种氨基糖苷类抗生素的抗菌活性比较(作者译)
Med Klin. 1978 Jun 16;73(24):914-7.
5
In vitro activity of amikacin and ten other aminoglycoside antibiotics against gentamicin-resistant bacterial strains.阿米卡星及其他十种氨基糖苷类抗生素对庆大霉素耐药菌株的体外活性
J Infect Dis. 1976 Nov;134 SUPPL:S291-6. doi: 10.1093/infdis/135.supplement_2.s291.
6
Susceptibility of aerobic gram-negative bacilli to aminoglycosides. Effects of 45 months of amikacin as first-line aminoglycoside therapy.需氧革兰氏阴性杆菌对氨基糖苷类药物的敏感性。阿米卡星作为一线氨基糖苷类药物治疗45个月的效果。
Am J Med. 1986 Jun 30;80(6B):65-70. doi: 10.1016/0002-9343(86)90481-x.
7
[Bacterial resistance to aminoglycoside antibiotics].[细菌对氨基糖苷类抗生素的耐药性]
Bratisl Lek Listy. 1992 Apr;93(4):175-8.
8
Newer aminoglycosides--amikacin and tobramycin: an in-vitro comparison with kanamycin and gentamicin.新型氨基糖苷类药物——阿米卡星和妥布霉素:与卡那霉素和庆大霉素的体外比较。
Br Med J. 1974 Sep 28;3(5934):778-80. doi: 10.1136/bmj.3.5934.778.
9
A novel multidrug resistance plasmid isolated from an Escherichia coli strain resistant to aminoglycosides.从一株对氨基糖苷类耐药的大肠杆菌中分离出的一种新型多药耐药质粒。
J Antimicrob Chemother. 2012 Jul;67(7):1635-8. doi: 10.1093/jac/dks107. Epub 2012 Apr 11.
10
Suceptibility of aminoglycoside-resistant gram-negative bacilli to amikacin: delineation of individual resistance patterns.耐氨基糖苷类革兰氏阴性杆菌对阿米卡星的敏感性:个体耐药模式的描述。
J Infect Dis. 1976 Nov;134 SUPPL:S280-5. doi: 10.1093/infdis/135.supplement_2.s280.

引用本文的文献

1
Whole-Genome Sequencing for Routine Pathogen Surveillance in Public Health: a Population Snapshot of Invasive Staphylococcus aureus in Europe.用于公共卫生常规病原体监测的全基因组测序:欧洲侵袭性金黄色葡萄球菌的人群概况
mBio. 2016 May 5;7(3):e00444-16. doi: 10.1128/mBio.00444-16.
2
Comparison of in vitro activity of Sch 21420, a gentamicin B derivative, with those of amikacin, gentamicin, netilmicin, sisomicin, and tobramycin.庆大霉素B衍生物Sch 21420与阿米卡星、庆大霉素、奈替米星、西索米星和妥布霉素的体外活性比较。
Antimicrob Agents Chemother. 1980 Aug;18(2):338-45. doi: 10.1128/AAC.18.2.338.
3
Which aminoglycoside?
用哪种氨基糖苷类药物?
Intensive Care Med. 1980 Aug;6(4):207-10. doi: 10.1007/BF01687158.
4
In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa.氨基糖苷类药物与新型β-内酰胺类药物对多重耐药铜绿假单胞菌的体外协同活性
Antimicrob Agents Chemother. 1984 Apr;25(4):534-6. doi: 10.1128/AAC.25.4.534.
5
Sisomicin, netilmicin and dibekacin. A review of their antibacterial activity and therapeutic use.西索米星、奈替米星和地贝卡星。对其抗菌活性和治疗用途的综述。
Drugs. 1984 Jun;27(6):548-78. doi: 10.2165/00003495-198427060-00003.
6
Decreased susceptibility to 4'-deoxy-6'-N-methylamikacin (BB-K311) conferred by a mutant plasmid in Escherichia coli.大肠杆菌中一种突变质粒赋予对4'-脱氧-6'-N-甲基阿米卡星(BB-K311)的敏感性降低
Antimicrob Agents Chemother. 1982 Jul;22(1):78-82. doi: 10.1128/AAC.22.1.78.
7
Netilmicin: new approach to treating gonorrhoea.奈替米星:治疗淋病的新方法。
Genitourin Med. 1987 Apr;63(2):95-7. doi: 10.1136/sti.63.2.95.
8
In vitro activity of Sch 21420, derivative of gentamicin B, compared to that of amikacin.庆大霉素B衍生物Sch 21420与阿米卡星的体外活性比较。
Antimicrob Agents Chemother. 1978 Nov;14(5):786-7. doi: 10.1128/AAC.14.5.786.
9
Aminoglycoside modification by gentamicin-resistant isolates of Staphylococcus aureus.金黄色葡萄球菌庆大霉素耐药菌株对氨基糖苷类的修饰作用。
Antimicrob Agents Chemother. 1978 Apr;13(4):641-4. doi: 10.1128/AAC.13.4.641.
10
Frequency of resistance to kanamycin, tobramycin, netilmicin, and amikacin in gentamicin-resistant gram-negative bacteria.庆大霉素耐药革兰氏阴性菌对卡那霉素、妥布霉素、奈替米星和阿米卡星的耐药频率。
Antimicrob Agents Chemother. 1978 Jan;13(1):70-3. doi: 10.1128/AAC.13.1.70.